ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Latest Update on Metformin
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 82386" data-attributes="member: 3"><p><span style="font-size: 15px"><span style="font-family: 'Arial'">A new HIV related study with Metformin currently enrolling.</span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">Anti-HIV drugs cut down the number of serious infections that people with HIV get. However, some subjects taking anti-HIV drugs do not achieve adequate cluster of differentiation 4 (CD4) recovery and decrease in elevated cluster of differentiation 8 (CD8) cells. Such patients with a low CD4/CD8 ratio remain at risk for developing acquired immune deficiency syndrome (AIDS) and non-AIDS-related complications. Two of the most important factors associated with low CD4/CD8 ratio include: the persistence of HIV on ART and inflammation.</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">Metformin, the most widely used medication to treat type 2 diabetes, is well tolerated with minimal side effects. It has been linked to anti-aging and weight reducing properties in non-diabetic persons. Because of its ability to improve immune functions, metformin could be a promising addition to ART in HIV patients. It is also reported to change the composition of microbes in the gut which may improve inflammation.</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">PURPOSES OF THE STUDY</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">The purposes of this study are to find out if:</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><ol> <li data-xf-list-type="ol"><span style="font-family: 'Arial'"><span style="font-size: 15px">metformin can be combined with anti-HIV drugs to reduce the amount of hidden virus in the body;</span></span></li> <li data-xf-list-type="ol"><span style="font-family: 'Arial'"><span style="font-size: 15px">metformin can be combined with anti-HIV drugs to improve immune function.</span></span></li> <li data-xf-list-type="ol"><span style="font-family: 'Arial'"><span style="font-size: 15px">metformin can be combined with anti-HIV drugs to impact CD4 T cell count and CD4/CD8 T cell ratio during treatment and after its discontinuation</span></span></li> <li data-xf-list-type="ol"><span style="font-family: 'Arial'"><span style="font-size: 15px">metformin can change the composition of the bacteria in the gut which may improve inflammation.</span></span></li> </ol><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">For this purpose, the investigators will add metformin at the usual antidiabetic dose for 12 weeks for patients receiving stable ART, having a CD4/CD8 ratio below 0.7.</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000">Approximately 22 participants will be enrolled in this study at the Chronic Viral Illness Service of the McGill University Health Centre, the Ottawa Hospital and the Maple Leaf Medical Clinic (Toronto). This study will last about 24 weeks; metformin treatment will be for 12 weeks. In order to be eligible for the study, the participants must be 18 years of age or older, have an undetectable viral load (the quantity of the HIV virus in the blood must be less than 50 copies/ml) for at least 3 months and have a CD4/CD8 ratio of less than 0.7. All participants will also be asked to give blood and stool samples and optional colon mucosal biopsy samples (before and after metformin supplementation) to study the size of the viral reservoir and the amount of T cell activation and changes in gut microbiota composition.</span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"><span style="color: #000000"><a href="https://clinicaltrials.gov/ct2/show/NCT02659306" target="_blank">Metformin Immunotherapy in HIV Infection - Full Text View - ClinicalTrials.gov</a></span></span></span></p><p><span style="font-family: 'Arial'"><span style="font-size: 15px"></span></span></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 82386, member: 3"] [SIZE=15px][FONT=Arial]A new HIV related study with Metformin currently enrolling.[/FONT][/SIZE] [FONT=Arial][SIZE=15px] [COLOR=#000000]Anti-HIV drugs cut down the number of serious infections that people with HIV get. However, some subjects taking anti-HIV drugs do not achieve adequate cluster of differentiation 4 (CD4) recovery and decrease in elevated cluster of differentiation 8 (CD8) cells. Such patients with a low CD4/CD8 ratio remain at risk for developing acquired immune deficiency syndrome (AIDS) and non-AIDS-related complications. Two of the most important factors associated with low CD4/CD8 ratio include: the persistence of HIV on ART and inflammation.[/COLOR] [COLOR=#000000]Metformin, the most widely used medication to treat type 2 diabetes, is well tolerated with minimal side effects. It has been linked to anti-aging and weight reducing properties in non-diabetic persons. Because of its ability to improve immune functions, metformin could be a promising addition to ART in HIV patients. It is also reported to change the composition of microbes in the gut which may improve inflammation.[/COLOR] [COLOR=#000000]PURPOSES OF THE STUDY[/COLOR] [COLOR=#000000]The purposes of this study are to find out if:[/COLOR] [/SIZE][/FONT] [LIST=1] [*][FONT=Arial][SIZE=15px]metformin can be combined with anti-HIV drugs to reduce the amount of hidden virus in the body;[/SIZE][/FONT] [*][FONT=Arial][SIZE=15px]metformin can be combined with anti-HIV drugs to improve immune function.[/SIZE][/FONT] [*][FONT=Arial][SIZE=15px]metformin can be combined with anti-HIV drugs to impact CD4 T cell count and CD4/CD8 T cell ratio during treatment and after its discontinuation[/SIZE][/FONT] [*][FONT=Arial][SIZE=15px]metformin can change the composition of the bacteria in the gut which may improve inflammation.[/SIZE][/FONT] [/LIST] [FONT=Arial][SIZE=15px][COLOR=#000000]For this purpose, the investigators will add metformin at the usual antidiabetic dose for 12 weeks for patients receiving stable ART, having a CD4/CD8 ratio below 0.7. Approximately 22 participants will be enrolled in this study at the Chronic Viral Illness Service of the McGill University Health Centre, the Ottawa Hospital and the Maple Leaf Medical Clinic (Toronto). This study will last about 24 weeks; metformin treatment will be for 12 weeks. In order to be eligible for the study, the participants must be 18 years of age or older, have an undetectable viral load (the quantity of the HIV virus in the blood must be less than 50 copies/ml) for at least 3 months and have a CD4/CD8 ratio of less than 0.7. All participants will also be asked to give blood and stool samples and optional colon mucosal biopsy samples (before and after metformin supplementation) to study the size of the viral reservoir and the amount of T cell activation and changes in gut microbiota composition.[/COLOR] [COLOR=#000000][URL="https://clinicaltrials.gov/ct2/show/NCT02659306"]Metformin Immunotherapy in HIV Infection - Full Text View - ClinicalTrials.gov[/URL][/COLOR] [/SIZE][/FONT] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Latest Update on Metformin
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top